Skip to main content
Caplight Logo









InBalance

InBalance

Private
—Healthcare & Life Scienceshttps://inbalance.ai/

Last Round

Accelerator

Mar 15, 2021

Est. Valuation

$1.79M

Total Funding Raised

$125,000

Company Overview

InBalance is a wellness technology company that provides a hormone-intelligent platform for tracking menstrual cycles and offering personalized recommendations for nutrition, movement, and rest.

Sector

Healthcare & Life Sciences

Verticals

Sports & Fitness, Patient Engagement, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

menstrual cycle trackinghormonal healthcycle syncingPCOS managementfemtechpersonalized wellnesshormone-intelligentdigital health apppolycystic ovary syndromePCOSsubscription SaaShealth trackingAI wellnessperiod tracker

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InBalance Comparables

Compare InBalance with similar companies based on industry and business-model similarity.

InBalance comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lively Cycle, LLC
89%
Moody Month
88%
28 Wellness
88%

InBalance Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMar 15, 2021

InBalance Investors

Notable investors and investment history

InBalance investors
InvestorRounds
Y CombinatorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 15, 2021

    $125K round led by Y Combinator

InBalance Filings

Explore SEC and related filing metadata, where available.

InBalance filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about InBalance's valuation, stock price, and market status.

Is InBalance a public or private company?

InBalance is a private company.

What is the current stock price of InBalance?

InBalance is a private company, so its shares have no public market price. Caplight tracks InBalance's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is InBalance worth (valuation)?

InBalance's valuation is estimated at $1.8M based on funding round data.

Can I buy InBalance stock?

InBalance shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was InBalance's last funding round?

InBalance's most recent funding round was Accelerator on March 15, 2021.

Who are the main investors in InBalance?

Key investors in InBalance include Y Combinator.

Will InBalance IPO soon?

No public IPO plans have been announced for InBalance.

How can I track InBalance secondary market activity?

Caplight tracks bids, offers, and trades in InBalance's shares on secondary markets.

Firmographic Details

Headquarters—
Year FoundedN/A
Last FundingMar 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?